Dme Capital Management, LP Liva Nova PLC Transaction History
Dme Capital Management, LP
- $2.04 Trillion
- Q2 2024
A detailed history of Dme Capital Management, LP transactions in Liva Nova PLC stock. As of the latest transaction made, Dme Capital Management, LP holds 644,269 shares of LIVN stock, worth $33.8 Million. This represents 1.73% of its overall portfolio holdings.
Number of Shares
644,269
Previous 1,332,804
51.66%
Holding current value
$33.8 Million
Previous $74.6 Billion
52.63%
% of portfolio
1.73%
Previous 3.41%
Shares
2 transactions
Others Institutions Holding LIVN
# of Institutions
249Shares Held
56.1MCall Options Held
566KPut Options Held
506K-
Black Rock Inc. New York, NY6.9MShares$363 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA5.98MShares$314 Million0.24% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$146 Million0.07% of portfolio
-
State Street Corp Boston, MA2.05MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$98.1 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.81B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...